Kit for the qualitative evaluation of the human mycobiota by PCR amplification of the ITS1 region of fungal ribosomal DNA (rDNA) and NGS sequencing.

Detailed Description

Operating Principle

Mycobiota Solution is based on the PCR amplification of the hypervariable ITS1 region of the fungal rDNA, using primers that allow the identification of most fungal populations present in the sample. The generated amplicons are subsequently sequenced by Next Generation Sequencing (NGS). The protocol includes eight stages: DNA extraction and quantification, Target PCR, purification of Target PCR products, Index PCR, purification of Index PCR products, normalization and pool preparation, sequencing, and data analysis.
Operating Principle Mycobiota Solution

Clinical Applications

The kit is intended for the qualitative evaluation of the human mycobiota given its relevance in multiple physiological conditions and pathological states (for example, mechanisms of colorectal carcinogenesis and fungal infections in immunocompromised patients).

Benefits

Qualitative, rapid (~8 hours), and highly sensitive DNA-based evaluation of the mycobiota, without relying on morphological analysis by culture. Automated post-sequencing analysis with dedicated software that generates reports on the fungal species identified in each sample and comparisons between samples selected by the user.

Technology Used

PCR amplification of the fungal rDNA ITS1 region followed by NGS.
Mycobiota Solution Workflow

Target Audience/User

This product is aimed at clinical microbiology or research laboratories that require a solution based on Next-Generation Sequencing (NGS) for the characterization of the human mycobiota. It is especially oriented towards users who need a protocol from library preparation to bioinformatic analysis for the study of fungal communities without relying on culture.

Considerations or Limitations

The kit is intended for manual use; any automation must be validated by the user. Data analysis with MicrobAT provides taxonomic assignment down to the species level for most reads, along with descriptive statistics such as rarefaction curves, alpha-diversity, and dysbiosis index.

Other Relevant Technical Information

Recommended extraction methods: QIAamp PowerFecal Pro DNA Kit or QIAamp Fast DNA Stool Mini Kit for feces, and DNeasy PowerSoil Pro Kit for other samples; other methods may be used following user validation. Requires a DNA input of 5–50 ng/µl. Compatibility with Illumina MiSeq™, iSeq 100™ and MiniSeq™ platforms. For optimal coverage of the amplified region, it is recommended to obtain at least 50,000 reads per sample.

Key Aspects

Qualitative evaluation of the human mycobiota via ITS1 PCR + NGS.
Library preparation ~8 hours.
Applicable to samples such as feces, rectal, vaginal, skin and oral swabs, saliva, sputum, and urine.
Avoids the culture phase and reduces the bias associated with laboratory culture conditions.
Dedicated software for per-sample and comparative reports, with descriptive diversity metrics.
Compatible with Illumina MiSeq™, Illumina iSeq 100™ and Illumina MiniSeq™.

Presentation Details

Format and References
AD-005.048 48 reactions
×

Area:

Fungus, Microbiology
Consult our experts

Google reCaptcha: Invalid site key.

Related products

Franklin by QIAGEN for Somatic Analysis

Advanced cloud-based bioinformatics platform designed for the automated analysis, interpretation, and classification of somatic variants in oncology. Through an integrated environment, the system evaluates clinical evidence in real time, automates classification in accordance with AMP/ASCO/CAP guidelines, and provides access to currently active clinical trials. Detailed description Operating principle End-to-end cloud-based solution for the clinical interpretation…
Qiagen
Next Generation Sequencing (NGS)

SeqOne Genomics – Somatic

SeqOne is a bioinformatics platform for NGS data analysis in precision oncology, designed to detect, prioritise and interpret somatic variants and generate actionable clinical reports from raw sequencing data. It helps laboratories and healthcare professionals accelerate the interpretation of NGS data through an end-to-end workflow. Detailed description Operating principle SeqOne Genomics is a genomic data…
SeqOne
Next Generation Sequencing (NGS)

MSK-ACCESS® powered with SOPHiA DDM™

In-house liquid biopsy solution based on hybrid-capture next-generation sequencing (NGS) technology for the ultrasensitive detection of somatic alterations in circulating cell-free DNA from plasma. Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it implements a robust matched tumor-normal sequencing approach (plasma cfDNA + white blood cell DNA) to filter germline variants and mutations…
SOPHIA Genetics
Next Generation Sequencing (NGS)

MSK-IMPACT® / MSK-IMPACT® FLEX

Decentralised, in-house comprehensive genomic profiling (CGP) solution for solid tumours, based on hybrid capture next-generation sequencing (NGS). Developed in collaboration with Memorial Sloan Kettering Cancer Center (MSK), it features a robust matched tumour-normal sequencing approach for filtering germline variants and clonal haematopoiesis. Detailed description Operating principle The decentralised MSK-IMPACT® powered with SOPHiA DDM™ solution enables…
SOPHIA Genetics
Next Generation Sequencing (NGS)